D-MYO-INOSITOL-1,2,6-TRISPHOSPHATE IS A SELECTIVE ANTAGONIST OF NEUROPEPTIDE Y-INDUCED PRESSOR-RESPONSES IN THE PITHED RAT

被引:38
作者
SUN, XY
DAHLOF, C
EDVINSSON, L
HEDNER, T
机构
[1] GOTHENBURG UNIV, DEPT CLIN PHARMACOL, S-40033 GOTHENBURG, SWEDEN
[2] SAHLGRENS UNIV HOSP, S-41345 GOTHENBURG, SWEDEN
[3] UNIV LUND HOSP, DEPT INTERNAL MED, S-22185 LUND, SWEDEN
关键词
NEUROPEPTIDE-Y (NPY); NPY RECEPTOR ANTAGONISTS; D-MYO-INOSITOL-1,2,6-TRISPHOSPHATE (PP56); BLOOD PRESSURE; CIRCULATION;
D O I
10.1016/0014-2999(91)90853-I
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The antagonistic effects of a new inositol phosphate derivative, D-myoinositol-1.2,6-trisphosphate (PP56), on pressor responses to preganglionic sympathetic nerve stimulation and exogenously administered phenylephrine or neuropeptide Y (NPY) were investigated in vivo in the pithed rat. In this model an intravenous (i.v.) bolus administration of PP56 (1-50 mg/kg) dose dependently inhibited the increase in mean arterial blood pressure (MAP) induced by a continuous infusion of NPY (2-mu-g/kg per min for 10 min). PP56 in a dose of 5 mg/kg i.v. bolus reduced the entire NPY dose-response curve (0.4-8-mu-g/kg per min 10 min infusion) without any shift to the right indicating a non-competitive interaction. Furthermore, PP56 (10-50 mg/kg i.v.) was found to inhibit the pressor response to preganglionic sympathetic nerve stimulation and i. v' bolus injection of the alpha-1-adrenoceptor agonist, phenylephrine. The dose-response curves for increasing doses of phenylephrine and incremental preganglionic sympathetic nerve stimulation were not significantly altered by a lower dose of PP56 (5 mg/kg i.v. bolus). We conclude that PP56, representing a new class of synthetic drugs, can antagonize the actions of exogenous and endogenous NPY in vivo, an action which is specific for NPY within a limited dose range.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 20 条
[1]  
AUTHI KS, 1989, THROMB HAEMOSTASIS, V62, P250
[2]   ALPHA-2-ADRENOCEPTOR-MEDIATED INHIBITION OF NERVE STIMULATION-EVOKED RELEASE OF NEUROPEPTIDE-Y (NPY)-LIKE IMMUNOREACTIVITY IN THE PITHED GUINEA-PIG [J].
DAHLOF, C ;
DAHLOF, P ;
LUNDBERG, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 131 (2-3) :279-283
[3]   NEUROPEPTIDE-Y (NPY) - ENHANCEMENT OF BLOOD-PRESSURE INCREASE UPON ALPHA-ADRENOCEPTOR ACTIVATION AND DIRECT PRESSOR EFFECTS IN PITHED RATS [J].
DAHLOF, C ;
DAHLOF, P ;
LUNDBERG, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 109 (02) :289-292
[4]   NEUROPEPTIDE-Y ANTAGONISTIC PROPERTIES OF D-MYO-INOSITOL-1.2.6-TRISPHOSPHATE IN GUINEA-PIG BASILAR ARTERIES [J].
EDVINSSON, L ;
ADAMSSON, M ;
JANSEN, I .
NEUROPEPTIDES, 1990, 17 (02) :99-105
[5]   NEUROPEPTIDE-Y POTENTIATES THE EFFECT OF VARIOUS VASOCONSTRICTOR AGENTS ON RABBIT-BLOOD VESSELS [J].
EDVINSSON, L ;
EKBLAD, E ;
HAKANSON, R ;
WAHLESTEDT, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (02) :519-525
[6]   EFFECTS OF NEUROPEPTIDE-Y ON THE CARDIOVASCULAR-SYSTEM [J].
EDVINSSON, L ;
HAKANSON, R ;
WAHLESTEDT, C ;
UDDMAN, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (06) :231-235
[7]   NEUROPEPTIDE-Y - CEREBROVASCULAR INNERVATION AND VASOMOTOR EFFECTS IN THE CAT [J].
EDVINSSON, L ;
EMSON, P ;
MCCULLOCH, J ;
TATEMOTO, K ;
UDDMAN, R .
NEUROSCIENCE LETTERS, 1983, 43 (01) :79-84
[8]   NEUROPEPTIDE-Y CO-EXISTS AND CO-OPERATES WITH NORADRENALINE IN PERIVASCULAR NERVE-FIBERS [J].
EKBLAD, E ;
EDVINSSON, L ;
WAHLESTEDT, C ;
UDDMAN, R ;
HAKANSON, R ;
SUNDLER, F .
REGULATORY PEPTIDES, 1984, 8 (03) :225-235
[9]   NEUROPEPTIDE-Y POTENTIATES CONTRACTION AND INHIBITS RELAXATION OF RABBIT CORONARY-ARTERIES [J].
HAN, C ;
ABEL, PW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (06) :675-681
[10]  
LINTONDAHLOF P, 1989, ACTA PHYSIOL SCAND, V137, P7